Skip to content

Clinical trials

Completed Schizophrenia trials in Greece

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Status: Completed Country / region: Greece Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20043
20052
20062
20074
20094
20102
20111
20121
20131
20141
20151
20161
20181
20191
20211
20221
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed30

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Janssen-Cilag International NV7
AstraZeneca3
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.3
Eli Lilly and Company2
KAVADIA ELENI2
Rakitzi, Stavroula2
Aristotle University Of Thessaloniki1
Boehringer Ingelheim1
Denovo Biopharma LLC1
Elpen Pharmaceutical Co. Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia30
Psychotic Disorders5
Bipolar Disorder4
Anxiety Disorders3
Autistic Disorder2
Adjustment Disorders1
Affective Disorders, Psychotic1
Anhedonia1
Autism Spectrum Disorder1
Cognitive Dysfunction1

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.